Objective: This study analyzed whether HPV (human papillomavirus) testing contributes towards defining histological abnormalities in women with atypical glandular cells (AGC) diagnosed at cervical cytology. Study design: One hundred and eight women with conventional cervical cancer screening smears suggestive of AGC not otherwise specified (AGC-NOS) and favor neoplastic (AGC-FN) were consecutively enrolled. All women underwent colposcopic examinations and biopsy was performed according to the cytopathologic and/or colposcopic abnormalities present. All specimens were tested for high risk HPV genotypes by Roche's polymerase chain reaction reverse line blot assay. The chi-square test was used to evaluate the association between HPV findings and a diagnosis of high-grade pre-invasive or invasive disease (CIN 2 or worse) taking negative tests or CIN 1 as a reference. Odds ratios (OR) with their respective 95% confidence intervals (95%CI) were used to evaluate the magnitude of the association between HPV testing and CIN 2 or worse. Sensitivity, specificity and their respective 95% confidence intervals (95%CI), positive predictive values (PPV) and negative predictive values (NPV) were also calculated. Results: Final diagnosis revealed a negative outcome in 80 cases (74%), cervical epithelial neoplasia 1 (CIN 1) in 13 cases (12%), CIN 2 or worse in 12 cases (11%) and glandular neoplasia in 3 (3%) cases. The overall detection rate of HPV was 21% (23/108). Neoplasia was significantly associated with positive HPV-DNA in women with AGC-NOS (OR = 15.21; 95%CI: 2.64-87.50); however, there was no significant association between a histological diagnosis of neoplasia and HPV positivity in women with AGC-FN (OR = 3.00; 95%CI: 0.36-24.92). The sensitivity, specificity, positive predictive value and negative predictive value of HPV-DNA testing for the detection of CIN 2 or worse in women with AGC-NOS were 71%, 86%, 29% and 97%, respectively. In women with AGC-FN, these values were 50%, 75%, 66% and 60%, respectively. Conclusions: HPV testing at the time of colposcopy for patients with AGC in whom no colposcopic abnormality is found may be a powerful ancillary tool for identifying women at a high risk of underlying significant cervical lesions. © 2011 Elsevier Ireland Ltd. All rights reserved.1591160164Smith, H.O., Tiffany, M.F., Qualls, C.R., Key, C.R., The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: A 24-year population based study (2000) Gynecol Oncol, 78, pp. 97-105Castellsague, X., Diaz, M., De Sanjose, S., Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: Implications for screening and prevention (2006) J Natl Cancer Inst, 98, pp. 303-315Bosch, F.X., Lorincz, A., Munoz, N., Meijer, C.J., Shah, K.V., The causal relation between human papillomavirus and cervical cancer (2002) J Clin Pathol, 55, pp. 244-265Covell, J.L., Wilbur, D.C., Guidos, B., Lee, K.R., Chhieng, D.C., Mody, D.R., Epithelial abnormalities: Glandular (2004) The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria and Explanatory Notes, pp. 123-156. , D. Solomon, R. Nayar, Springer New YorkZaino, R.J., Symposium part I: Adenocarcinoma in situ, glandular dysplasia, and early invasive adenocarcinoma of the uterine cervix (2002) Int J Gynecol Pathol, 21, pp. 314-326Herzog, T.J., Monk, B.J., Reducing the burden of glandular carcinomas of the uterine cervix (2007) Am J Obstet Gynecol, pp. 566-571Diaz-Montes, T.P., Farinola, M.A., Zahurak, M.L., Clinical utility of atypical glandular cells (AGC) classification: Cytohistologic comparison and relationship to HPV results (2007) Gynecol Oncol, 104, pp. 366-371Rabelo-Santos, S.H., Derchain, S.F., Do Amaral Westin, M.C., Endocervical glandular cell abnormalities in conventional cervical smears: Evaluation of the performance of cytomorphological criteria and HPV testing in predicting neoplasia (2008) Cytopathology, 19, pp. 34-43Westin, M.C., Derchain, S.F., Rabelo-Santos, S.H., Atypical glandular cells and adenocarcinoma in situ according to the Bethesda 2001 classification: Cytohistological correlation and clinical implications (2008) Eur J Obstet Gynecol Reprod Biol, 139, pp. 79-85Derchain, S.F., Rabelo-Santos, S.H., Sarian, L.O., Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears (2004) Gynecol Oncol, 95, pp. 618-623Krane, J.F., Lee, K.R., Sun, D., Yuan, L., Crum, C.P., Atypical glandular cells of undetermined significance. Outcome predictions based on human papillomavirus testing (2004) Am J Clin Pathol, 121, pp. 87-92Rabelo-Santos, S.H., Derchain, S.F., Villa, L.L., Human papillomavirus specific genotypes in cervical lesions of women referred for smears with atypical glandular cells or adenocarcinoma in situ (2009) Int J Gynecol Pathol, 28, pp. 272-278Rabelo-Santos, S.H., Villa, L.L., Derchain, S.F., Variants of human papillomavirus types 16 and 18: Histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in cervical smear (2006) Int J Gynecol Pathol, 25, pp. 393-397Wright, Jr.T.C., Massad, L.S., Dunton, C.J., 2006 Consensus guidelines for the management of women with abnormal cervical cancer screening tests (2007) Am J Obstet Gynecol, 197, pp. 346-355Wright, Jr.T.C., Cox, J.T., Massad, L.S., 2001 Consensus guidelines for the management of women with cervical cytological abnormalities (2002) JAMA, 287, pp. 2120-2129Schnatz, P.F., Sharpless, K.E., O'Sullivan, D.M., Use of human papillomavirus testing in the management of atypical glandular cells (2009) J Low Genit Tract Dis, 13 (2), pp. 94-101Zhao, C., Austin, R.M., Pan, J., Clinical significance of atypical glandular cells in conventional pap smears in a large, high-risk U.S. west coast minority population (2009) Acta Cytol, 53 (2), pp. 153-159Chen, L., Yang, B., Assessment of reflex human papillomavirus DNA testing in patients with atypical endocervical cells on cervical cytology (2008) Cancer, 114, pp. 236-241Gravitt, P.E., Peyton, C.L., Apple, R.J., Wheeler, C.M., Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method (1998) J Clin Microbiol, 36, pp. 3020-3027Gravitt, P.E., Peyton, C.L., Alessi, T.Q., Improved amplification of genital human papillomaviruses (2000) J Clin Microbiol, 38, pp. 357-361Gravitt, P.E., Schiffman, M., Solomon, D., Wheeler, C.M., Castle, P.E., A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study (2008) Cancer Epidemiol Biomarkers Prev, 17 (5), pp. 1248-1254Scully, R.E., Bonfiglio, T.A., Kurman, R.J., Silverberg, S.G., Wilkins, E.J., Histological typing of female genital tract tumors (1994) World Health Organization - International Histological Classification of Tumors, , 2nd ed. Springer-Verlag Berlin pp. 36-49Sharpless, K.E., O'Sullivan, D.M., Schnatz, P.F., The utility of human papillomavirus testing in the management of atypical glandular cells on cytology (2009) J Low Genit Tract Dis, 13 (2), pp. 72-78Castle, P.E., Fetterman, B., Poitras, N., Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks (2010) Obstet Gynecol, 115 (2 PART 1), pp. 243-248Saqi, A., Gupta, P.K., Erroll, M., High-risk human papillomavirus DNA testing: A marker for atypical glandular cells (2006) Diagn Cytopathol, 34, pp. 235-239